Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Markus Nauck

Showing results (11-20 of 19) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 19 results.
Journal of Molecular Medicine (Berlin, Germany)|December 16, 2004
Association of angiotensinogen haplotypes with angiotensinogen levels but not with blood pressure or coronary artery disease: the Ludwigshafen Risk and Cardiovascular Health StudyWilfried Renner, Markus Nauck, Bernhard R Winkelmann, et al.
Circulation|June 3, 2004
G(-30)A polymorphism in the pancreatic promoter of the glucokinase gene associated with angiographic coronary artery disease and type 2 diabetes mellitusWinfried März, Markus Nauck, Michael M Hoffmann, et al.
Circulation|February 16, 2005
Platelet-activating factor acetylhydrolase activity indicates angiographic coronary artery disease independently of systemic inflammation and other risk factors: the Ludwigshafen Risk and Cardiovascular Health StudyKarl Winkler, Bernhard R Winkelmann, Hubert Scharnagl, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|August 23, 2005
Adiponectin serum concentrations in men with coronary artery disease: the LUdwigshafen RIsk and Cardiovascular Health (LURIC) studyStefan Pilz, Winfried Maerz, Gisela Weihrauch, et al.
Orphanet Journal of Rare Diseases|September 4, 2012
Targeted next-generation sequencing identifies a homozygous nonsense mutation in ABHD12, the gene underlying PHARC, in a family clinically diagnosed with Usher syndrome type 3Tobias Eisenberger, Rima Slim, Ahmad Mansour, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|February 8, 2018
Substantial variation in the hepatitis B surface antigen (HBsAg) in hepatitis B virus (HBV)-positive patients from South Africa: Reliable detection of HBV by the Elecsys HBsAg II assayMikael Gencay, Marion Vermeulen, Dionysis Neofytos, et al.
The Journal of Clinical Endocrinology and Metabolism|August 23, 2007
Thyroid hormone replacement for central hypothyroidism: a randomized controlled trial comparing two doses of thyroxine (T4) with a combination of T4 and triiodothyronineMarc Slawik, Björn Klawitter, Edith Meiser, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|April 15, 2018
Frequency of hepatitis B surface antigen variants (HBsAg) in hepatitis B virus genotype B and C infected East- and Southeast Asian patients: Detection by the Elecsys<sup>®</sup> HBsAg II assayHyon Suk Kim, Xinyue Chen, Min Xu, et al.
Plos One|May 5, 2017
Ultra-deep sequencing reveals high prevalence and broad structural diversity of hepatitis B surface antigen mutations in a global populationMikael Gencay, Kirsten Hübner, Peter Gohl, et al.
Pageof 2

Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Journal of Molecular Medicine (Berlin, Germany)|December 16, 2004
Association of angiotensinogen haplotypes with angiotensinogen levels but not with blood pressure or coronary artery disease: the Ludwigshafen Risk and Cardiovascular Health StudyWilfried Renner, Markus Nauck, Bernhard R Winkelmann, et al.
Circulation|June 3, 2004
G(-30)A polymorphism in the pancreatic promoter of the glucokinase gene associated with angiographic coronary artery disease and type 2 diabetes mellitusWinfried März, Markus Nauck, Michael M Hoffmann, et al.
Circulation|February 16, 2005
Platelet-activating factor acetylhydrolase activity indicates angiographic coronary artery disease independently of systemic inflammation and other risk factors: the Ludwigshafen Risk and Cardiovascular Health StudyKarl Winkler, Bernhard R Winkelmann, Hubert Scharnagl, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|August 23, 2005
Adiponectin serum concentrations in men with coronary artery disease: the LUdwigshafen RIsk and Cardiovascular Health (LURIC) studyStefan Pilz, Winfried Maerz, Gisela Weihrauch, et al.
Orphanet Journal of Rare Diseases|September 4, 2012
Targeted next-generation sequencing identifies a homozygous nonsense mutation in ABHD12, the gene underlying PHARC, in a family clinically diagnosed with Usher syndrome type 3Tobias Eisenberger, Rima Slim, Ahmad Mansour, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|February 8, 2018
Substantial variation in the hepatitis B surface antigen (HBsAg) in hepatitis B virus (HBV)-positive patients from South Africa: Reliable detection of HBV by the Elecsys HBsAg II assayMikael Gencay, Marion Vermeulen, Dionysis Neofytos, et al.
The Journal of Clinical Endocrinology and Metabolism|August 23, 2007
Thyroid hormone replacement for central hypothyroidism: a randomized controlled trial comparing two doses of thyroxine (T4) with a combination of T4 and triiodothyronineMarc Slawik, Björn Klawitter, Edith Meiser, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|April 15, 2018
Frequency of hepatitis B surface antigen variants (HBsAg) in hepatitis B virus genotype B and C infected East- and Southeast Asian patients: Detection by the Elecsys<sup>®</sup> HBsAg II assayHyon Suk Kim, Xinyue Chen, Min Xu, et al.
Plos One|May 5, 2017
Ultra-deep sequencing reveals high prevalence and broad structural diversity of hepatitis B surface antigen mutations in a global populationMikael Gencay, Kirsten Hübner, Peter Gohl, et al.
Pageof 2